Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;24(3):163-6.
doi: 10.1002/jcla.20383.

Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality

Affiliations

Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality

P Onguru et al. J Clin Lab Anal. 2010.

Abstract

Background: Crimean-Congo hemorrhagic fever (CCHF) is an acute illness affecting multiple organ systems and characterized by ecchymosis, visceral bleeding, and hepatic dysfunction. In this study, we aimed to investigate the profile of coagulopathy markers (platelet count, activated partial tromboplastin time (aPTT), prothrombin time (PT), international normalized ratio (INR), fibrinogen, protein C, protein S, antithrombin III, activated protein C resistance (APCR), and D-dimer) and their clinical significance in 83 CCHF-infected patients.

Subjects and methods: We studied 83 CCHF patients who were admitted to Ankara Numune Education and Research Hospital during the spring and summer of2007. We compared the coagulopathy markers of fatal CCHF patients (n=9) with nonfatal cases (n=74).

Results: Platelet count, PT, aPTT, INR, and fibrinogen were prognostic factors associated with mortality for CCHF. Especially, platelet count<20 x 10(9) cells/l and aPTT>60 sec were important. Protein C, protein S, APCR, and antithrombin III levels were not associated with mortality.

Conclusion: Laboratory tests including classical parameters (platelet count, PT, aPTT, INR, and fibrinogen) of coagulopathy seem to be enough for the followup of CCHF. Protein S, protein C, APCR, and D-dimer levels were not associated with mortality.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Whitehouse CA. Crimean‐Congo hemorrhagic fever. Antiviral Res 2004;64:145–160. - PubMed
    1. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean‐Congo hemorrhagic fever. Rev Infect Dis 1989;11:794–800. - PubMed
    1. Vorou R, Pierroutsakos IN, Maltezou HC. Crimean‐Congo hemorrhagic fever. Curr Oppin Infect Dis 2007;20:495–500. - PubMed
    1. Centers for Disease Control and Prevention (CDC) . Update: management of patients with suspected viral hemorrhagic fever‐United States. MMWR Morb Mortal Wkly Rep 1995;44:475–479. - PubMed
    1. Cevik MA, Erbay A, Bodur H, et al. Clinical and laboratory features of Crimean‐Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008;12:374–379. - PubMed

MeSH terms